Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review

BACKGROUND: Methotrexate (MTX) is the cornerstone disease-modifying anti-rheumatic drug in juvenile idiopathic arthritis (JIA). In JIA, it is important to start effective treatment early to avoid long-term sequelae, such as joint damage. To accomplish this goal, it is crucial to know beforehand who...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijkhuizen, EH Pieter, Wulffraat, Nico M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269851/
https://www.ncbi.nlm.nih.gov/pubmed/25525416
http://dx.doi.org/10.1186/1546-0096-12-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269851/
https://www.ncbi.nlm.nih.gov/pubmed/25525416
http://dx.doi.org/10.1186/1546-0096-12-51

Ejemplares similares